What is a desmoid tumor? A desmoid tumor is a rare fibrous growth that can start in the arms, legs, or torso (body). They most commonly grow in the abdomen (belly). These tumors start in connective ...

Diagnosed with a rare condition at age 18, Mackenzie Wilmoth has recovered, and she's leading the efforts to help those ...

The results of the DeFi trial of nirogacestat in 142 adults with progressing desmoid tumours showed a significant 71% improvement with the drug on progression-free survival (PFS) compared to ...

The FDA approved SpringWorks’ Ogsiveo (nirogacestat) for treating adult patients with desmoid tumors who require systemic treatment in November 2023. Following the FDA nod, not only Ogsiveo ...

Two years later, Nansi, from Criccieth in Gwynedd, was diagnosed with desmoid-type fibromatosis (DF), a rare type of soft tissue tumour. "The doctors should have listened to me. I’m her mother ...

Nansi was diagnosed with a desmoid-type fibromatosis (DF) - a rare type of intermediate soft tissue tumour, which sits somewhere between non-cancerous and cancerous. DF itself is not specifically ...

Pipeline Highlights Full enrollment for the Phase 3 RINGSIDE Part B study of AL102 for the treatment of desmoid tumors was completed in February 2024, and Immunome continues to expect to report ...

The stock got a huge boost in early February when Immunome announced plans to acquire desmoid tumor treatment candidate AL102 from Ayala Pharmaceuticals for $50 million. AL102 is a potential daily ...

today announced that it will present a poster with updated results from the RINGSIDE Phase 2 clinical trial of AL102 for the treatment of desmoid tumors at the European Society of Medical Oncology ...

J.P. Morgan analyst Anupam Rama maintained a Buy rating on Springworks Therapeutics (SWTX – Research Report) today and set a price target ...